Chiara Cimmaruta - Concepedia

Author

Chiara Cimmaruta

University of Naples Federico II ORCID

Also Known As

Chiara Cimmaruta, Cimmaruta, Chiara

Publications

233

Citations

H-Index

Concepts

All Affiliations

University of Naples Federico II Istituto di Chimica Biomolecolare University of Campania "Luigi Vanvitelli"University of Rostock German Center for Neurodegenerative Diseases

About

Chiara Cimmaruta is an author at University of Naples Federico II specializing in natural sciences, proteomics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	86
2	Natural Sciences	4	4	86
3	Biochemistry	3	3	67
4	Cell Biology	3	3	56
5	Biomolecular Engineering	1	1	19

Chiara Cimmaruta

Publications

181

Citations

H-Index

Page 1

	Year	Citations
The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers Valentina Citro, Chiara Cimmaruta, Maria Monticelli, International Journal of Molecular Sciences	2018	40
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase Chiara Cimmaruta, Valentina Citro, Giuseppina Andreotti, BMC Bioinformatics	2018	31
Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease Valentina Citro, Jorge Peña‐García, Helena den-Haan, PLoS ONE Drug TargetGlycobiologyAllosteric Binding SiteMolecular BiologyLigand Binding	2016	30
Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease Jan Lukáš, Chiara Cimmaruta, Ludovica Liguori, International Journal of Molecular Sciences	2020	24
Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease Susanne Seemann, Mathias Ernst, Chiara Cimmaruta, Biochemical Journal Molecular RegulationGeneticsEffective PrsProteomic TechnologyProtein Expression	2020	23
Enzyme Replacement Therapy for FABRY Disease: Possible Strategies to Improve Its Efficacy Ilaria Iacobucci, Bruno Hay Mele, Flora Cozzolino, International Journal of Molecular Sciences Enzyme Replacement TherapyPossible StrategiesGlycobiologyPathologyBiological Therapy	2023	19
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG Valentina Citro, Chiara Cimmaruta, Ludovica Liguori, PLoS ONE Protein GlycosylationTriple MutantBiochemistryCellular EnzymologyNatural Sciences	2017	14

Page 1